|
private:pappasventures
|
70317
|
May 31st, 2019 12:00AM
|
Pappas Capital
|
743
|
24.00
|
Open
|
Venture Capital & Private Equity
|
May 30th, 2019 08:04PM
|
May 30th, 2019 08:04PM
|
Pappas Capital is laser focused on the life science sector. For nearly 25 years we have been investing in and building innovative companies that are developing the next generation of life science products and technologies. We’ve invested in more than 75 companies across the United States and Canada – in fields that span the range of human disease. The products our companies have brought to market – for treating such conditions as melanoma, ovarian cancer, and hemophilia, to name a few – have been used throughout the world to treat tens of thousands of patients and account for billions of dollars of revenue.
Whether you’re looking for capital or have capital to invest, contact us and learn how we can put our expertise to work for you.
|
Open
|
Biotechnology, Biopharmaceuticals, Drug Delivery, Medical Devices
|
Open
|
2520 Meridian Pkwy, Suite 400
|
Durham
|
North Carolina
|
US
|
27713
|
|
Pappas Ventures
|
|
Health Care Equipment & Services
|
|
private:pappasventures
|
70317
|
Mar 19th, 2018 12:00AM
|
Pappas Ventures
|
621
|
23.00
|
Open
|
Venture Capital & Private Equity
|
Mar 18th, 2018 10:12PM
|
Mar 18th, 2018 10:12PM
|
|
Open
|
|
|
|
|
|
|
|
|
Pappas Ventures
|
|
Health Care Equipment & Services
|
|
private:pappasventures
|
70317
|
Feb 17th, 2018 12:00AM
|
Pappas Ventures
|
584
|
23.00
|
Open
|
Venture Capital & Private Equity
|
Feb 17th, 2018 02:25PM
|
Feb 17th, 2018 02:25PM
|
Pappas Ventures is focused exclusively on investing in the life sciences sector across North America. Our team brings experience, creativity and passion to every partnership, from concept to commercialization, carefully guiding the most promising technologies to market.
Founded in 1994, Pappas Ventures invests in biotechnology, biopharmaceuticals, drug delivery, medical devices and related ventures. We have more than $350 million in capital under management and have guided the launch and/or development of 57 companies. With longstanding relationships throughout the industry, we’re able to help our portfolio companies find talent for their teams. Our in-depth knowledge of the drug development process enables our management teams to provide insightful guidance and craft effective clinical and regulatory strategies. We also endeavor to further the life of companies by leveraging our extensive professional network.
Pappas Ventures invests in companies across a wide range of stages, from preclinical companies that are within a year of initiating human clinical trials to companies ready to begin Phase 3 studies. We’re always interested in new opportunities and we want to hear from you, contact us at dealflowmanager@pappasventures.com.
|
|
|
|
|
|
|
|
|
|
Pappas Ventures
|
|
Health Care Equipment & Services
|
|
private:pappasventures
|
70317
|
Feb 16th, 2018 12:00AM
|
Pappas Ventures
|
584
|
23.00
|
Open
|
Venture Capital & Private Equity
|
Feb 16th, 2017 08:15AM
|
Feb 16th, 2017 08:15AM
|
Pappas Ventures is focused exclusively on investing in the life sciences sector across North America. Our team brings experience, creativity and passion to every partnership, from concept to commercialization, carefully guiding the most promising technologies to market.
Founded in 1994, Pappas Ventures invests in biotechnology, biopharmaceuticals, drug delivery, medical devices and related ventures. We have more than $350 million in capital under management and have guided the launch and/or development of 57 companies. With longstanding relationships throughout the industry, we’re able to help our portfolio companies find talent for their teams. Our in-depth knowledge of the drug development process enables our management teams to provide insightful guidance and craft effective clinical and regulatory strategies. We also endeavor to further the life of companies by leveraging our extensive professional network.
Pappas Ventures invests in companies across a wide range of stages, from preclinical companies that are within a year of initiating human clinical trials to companies ready to begin Phase 3 studies. We’re always interested in new opportunities and we want to hear from you, contact us at dealflowmanager@pappasventures.com.
|
|
|
|
|
|
|
|
|
|
Pappas Ventures
|
|
Health Care Equipment & Services
|
|
private:pappasventures
|
70317
|
Feb 15th, 2018 12:00AM
|
Pappas Ventures
|
584
|
23.00
|
Open
|
Venture Capital & Private Equity
|
Feb 15th, 2017 10:07AM
|
Feb 15th, 2017 10:07AM
|
Pappas Ventures is focused exclusively on investing in the life sciences sector across North America. Our team brings experience, creativity and passion to every partnership, from concept to commercialization, carefully guiding the most promising technologies to market.
Founded in 1994, Pappas Ventures invests in biotechnology, biopharmaceuticals, drug delivery, medical devices and related ventures. We have more than $350 million in capital under management and have guided the launch and/or development of 57 companies. With longstanding relationships throughout the industry, we’re able to help our portfolio companies find talent for their teams. Our in-depth knowledge of the drug development process enables our management teams to provide insightful guidance and craft effective clinical and regulatory strategies. We also endeavor to further the life of companies by leveraging our extensive professional network.
Pappas Ventures invests in companies across a wide range of stages, from preclinical companies that are within a year of initiating human clinical trials to companies ready to begin Phase 3 studies. We’re always interested in new opportunities and we want to hear from you, contact us at dealflowmanager@pappasventures.com.
|
|
|
|
|
|
|
|
|
|
Pappas Ventures
|
|
Health Care Equipment & Services
|
|
private:pappasventures
|
70317
|
Feb 14th, 2018 12:00AM
|
Pappas Ventures
|
584
|
23.00
|
Open
|
Venture Capital & Private Equity
|
Feb 14th, 2017 01:50PM
|
Feb 14th, 2017 01:50PM
|
Pappas Ventures is focused exclusively on investing in the life sciences sector across North America. Our team brings experience, creativity and passion to every partnership, from concept to commercialization, carefully guiding the most promising technologies to market.
Founded in 1994, Pappas Ventures invests in biotechnology, biopharmaceuticals, drug delivery, medical devices and related ventures. We have more than $350 million in capital under management and have guided the launch and/or development of 57 companies. With longstanding relationships throughout the industry, we’re able to help our portfolio companies find talent for their teams. Our in-depth knowledge of the drug development process enables our management teams to provide insightful guidance and craft effective clinical and regulatory strategies. We also endeavor to further the life of companies by leveraging our extensive professional network.
Pappas Ventures invests in companies across a wide range of stages, from preclinical companies that are within a year of initiating human clinical trials to companies ready to begin Phase 3 studies. We’re always interested in new opportunities and we want to hear from you, contact us at dealflowmanager@pappasventures.com.
|
|
|
|
|
|
|
|
|
|
Pappas Ventures
|
|
Health Care Equipment & Services
|
|
private:pappasventures
|
70317
|
Feb 13th, 2018 12:00AM
|
Pappas Ventures
|
584
|
23.00
|
Open
|
Venture Capital & Private Equity
|
Feb 13th, 2017 04:11PM
|
Feb 13th, 2017 04:11PM
|
Pappas Ventures is focused exclusively on investing in the life sciences sector across North America. Our team brings experience, creativity and passion to every partnership, from concept to commercialization, carefully guiding the most promising technologies to market.
Founded in 1994, Pappas Ventures invests in biotechnology, biopharmaceuticals, drug delivery, medical devices and related ventures. We have more than $350 million in capital under management and have guided the launch and/or development of 57 companies. With longstanding relationships throughout the industry, we’re able to help our portfolio companies find talent for their teams. Our in-depth knowledge of the drug development process enables our management teams to provide insightful guidance and craft effective clinical and regulatory strategies. We also endeavor to further the life of companies by leveraging our extensive professional network.
Pappas Ventures invests in companies across a wide range of stages, from preclinical companies that are within a year of initiating human clinical trials to companies ready to begin Phase 3 studies. We’re always interested in new opportunities and we want to hear from you, contact us at dealflowmanager@pappasventures.com.
|
|
|
|
|
|
|
|
|
|
Pappas Ventures
|
|
Health Care Equipment & Services
|
|
private:pappasventures
|
70317
|
Feb 12th, 2018 12:00AM
|
Pappas Ventures
|
584
|
23.00
|
Open
|
Venture Capital & Private Equity
|
Feb 12th, 2017 04:15AM
|
Feb 12th, 2017 04:15AM
|
Pappas Ventures is focused exclusively on investing in the life sciences sector across North America. Our team brings experience, creativity and passion to every partnership, from concept to commercialization, carefully guiding the most promising technologies to market.
Founded in 1994, Pappas Ventures invests in biotechnology, biopharmaceuticals, drug delivery, medical devices and related ventures. We have more than $350 million in capital under management and have guided the launch and/or development of 57 companies. With longstanding relationships throughout the industry, we’re able to help our portfolio companies find talent for their teams. Our in-depth knowledge of the drug development process enables our management teams to provide insightful guidance and craft effective clinical and regulatory strategies. We also endeavor to further the life of companies by leveraging our extensive professional network.
Pappas Ventures invests in companies across a wide range of stages, from preclinical companies that are within a year of initiating human clinical trials to companies ready to begin Phase 3 studies. We’re always interested in new opportunities and we want to hear from you, contact us at dealflowmanager@pappasventures.com.
|
|
|
|
|
|
|
|
|
|
Pappas Ventures
|
|
Health Care Equipment & Services
|
|
private:pappasventures
|
70317
|
Feb 11th, 2018 12:00AM
|
Pappas Ventures
|
584
|
23.00
|
Open
|
Venture Capital & Private Equity
|
Feb 11th, 2017 05:35AM
|
Feb 11th, 2017 05:35AM
|
Pappas Ventures is focused exclusively on investing in the life sciences sector across North America. Our team brings experience, creativity and passion to every partnership, from concept to commercialization, carefully guiding the most promising technologies to market.
Founded in 1994, Pappas Ventures invests in biotechnology, biopharmaceuticals, drug delivery, medical devices and related ventures. We have more than $350 million in capital under management and have guided the launch and/or development of 57 companies. With longstanding relationships throughout the industry, we’re able to help our portfolio companies find talent for their teams. Our in-depth knowledge of the drug development process enables our management teams to provide insightful guidance and craft effective clinical and regulatory strategies. We also endeavor to further the life of companies by leveraging our extensive professional network.
Pappas Ventures invests in companies across a wide range of stages, from preclinical companies that are within a year of initiating human clinical trials to companies ready to begin Phase 3 studies. We’re always interested in new opportunities and we want to hear from you, contact us at dealflowmanager@pappasventures.com.
|
|
|
|
|
|
|
|
|
|
Pappas Ventures
|
|
Health Care Equipment & Services
|
|
private:pappasventures
|
70317
|
Feb 10th, 2018 12:00AM
|
Pappas Ventures
|
584
|
23.00
|
Open
|
Venture Capital & Private Equity
|
Feb 10th, 2017 06:43AM
|
Feb 10th, 2017 06:43AM
|
Pappas Ventures is focused exclusively on investing in the life sciences sector across North America. Our team brings experience, creativity and passion to every partnership, from concept to commercialization, carefully guiding the most promising technologies to market.
Founded in 1994, Pappas Ventures invests in biotechnology, biopharmaceuticals, drug delivery, medical devices and related ventures. We have more than $350 million in capital under management and have guided the launch and/or development of 57 companies. With longstanding relationships throughout the industry, we’re able to help our portfolio companies find talent for their teams. Our in-depth knowledge of the drug development process enables our management teams to provide insightful guidance and craft effective clinical and regulatory strategies. We also endeavor to further the life of companies by leveraging our extensive professional network.
Pappas Ventures invests in companies across a wide range of stages, from preclinical companies that are within a year of initiating human clinical trials to companies ready to begin Phase 3 studies. We’re always interested in new opportunities and we want to hear from you, contact us at dealflowmanager@pappasventures.com.
|
|
|
|
|
|
|
|
|
|
Pappas Ventures
|
|
Health Care Equipment & Services
|